These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. A Hyperstabilizing Mutation in the Base of the Ebola Virus Glycoprotein Acts at Multiple Steps To Abrogate Viral Entry. Fels JM; Spence JS; Bortz RH; Bornholdt ZA; Chandran K mBio; 2019 Jul; 10(4):. PubMed ID: 31289183 [TBL] [Abstract][Full Text] [Related]
9. Functional Interplay Between Murine Leukemia Virus Glycogag, Serinc5, and Surface Glycoprotein Governs Virus Entry, with Opposite Effects on Gammaretroviral and Ebolavirus Glycoproteins. Ahi YS; Zhang S; Thappeta Y; Denman A; Feizpour A; Gummuluru S; Reinhard B; Muriaux D; Fivash MJ; Rein A mBio; 2016 Nov; 7(6):. PubMed ID: 27879338 [TBL] [Abstract][Full Text] [Related]
10. Folate receptor-alpha is a cofactor for cellular entry by Marburg and Ebola viruses. Chan SY; Empig CJ; Welte FJ; Speck RF; Schmaljohn A; Kreisberg JF; Goldsmith MA Cell; 2001 Jul; 106(1):117-26. PubMed ID: 11461707 [TBL] [Abstract][Full Text] [Related]
11. Endoproteolytic processing of the ebola virus envelope glycoprotein: cleavage is not required for function. Wool-Lewis RJ; Bates P J Virol; 1999 Feb; 73(2):1419-26. PubMed ID: 9882347 [TBL] [Abstract][Full Text] [Related]
12. Enhancement of Ebola Virus Infection via Ficolin-1 Interaction with the Mucin Domain of GP Glycoprotein. Favier AL; Gout E; Reynard O; Ferraris O; Kleman JP; Volchkov V; Peyrefitte C; Thielens NM J Virol; 2016 Jun; 90(11):5256-5269. PubMed ID: 26984723 [TBL] [Abstract][Full Text] [Related]
13. Intracellular trafficking of Gag and Env proteins and their interactions modulate pseudotyping of retroviruses. Sandrin V; Muriaux D; Darlix JL; Cosset FL J Virol; 2004 Jul; 78(13):7153-64. PubMed ID: 15194792 [TBL] [Abstract][Full Text] [Related]
14. A Polymorphism within the Internal Fusion Loop of the Ebola Virus Glycoprotein Modulates Host Cell Entry. Hoffmann M; Crone L; Dietzel E; Paijo J; González-Hernández M; Nehlmeier I; Kalinke U; Becker S; Pöhlmann S J Virol; 2017 May; 91(9):. PubMed ID: 28228590 [TBL] [Abstract][Full Text] [Related]
15. Characterization of Human and Murine T-Cell Immunoglobulin Mucin Domain 4 (TIM-4) IgV Domain Residues Critical for Ebola Virus Entry. Rhein BA; Brouillette RB; Schaack GA; Chiorini JA; Maury W J Virol; 2016 Jul; 90(13):6097-6111. PubMed ID: 27122575 [TBL] [Abstract][Full Text] [Related]
17. Studies of ebola virus glycoprotein-mediated entry and fusion by using pseudotyped human immunodeficiency virus type 1 virions: involvement of cytoskeletal proteins and enhancement by tumor necrosis factor alpha. Yonezawa A; Cavrois M; Greene WC J Virol; 2005 Jan; 79(2):918-26. PubMed ID: 15613320 [TBL] [Abstract][Full Text] [Related]
18. Differences in the internalization of self-inactivating VSVG-pseudotyped murine leukemia virus-based vectors in human and murine cells. Acevedo ML; García-de Gracia F; Miranda-Cárdenas C; Soto-Rifo R; Aguayo F; León O J Virol Methods; 2018 May; 255():14-22. PubMed ID: 29425681 [TBL] [Abstract][Full Text] [Related]
19. Reverse genetics demonstrates that proteolytic processing of the Ebola virus glycoprotein is not essential for replication in cell culture. Neumann G; Feldmann H; Watanabe S; Lukashevich I; Kawaoka Y J Virol; 2002 Jan; 76(1):406-10. PubMed ID: 11739705 [TBL] [Abstract][Full Text] [Related]
20. Oncoretrovirus and lentivirus vectors pseudotyped with lymphocytic choriomeningitis virus glycoprotein: generation, concentration, and broad host range. Beyer WR; Westphal M; Ostertag W; von Laer D J Virol; 2002 Feb; 76(3):1488-95. PubMed ID: 11773421 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]